DiaMedica Therapeutics (DMAC)
(Delayed Data from NSDQ)
$4.03 USD
+0.18 (4.68%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $4.03 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2024
Time: -- |
9/2024 | $-0.16 | 0.00% |
Earnings Summary
For their last quarter, DiaMedica Therapeutics (DMAC) reported earnings of -$0.13 per share, beating the Zacks Consensus Estimate of $-0.16 per share. This reflects a positive earnings surprise of 18.75%. Look out for DMAC's next earnings release expected on November 11, 2024. For the next earning release, we expect the company to report earnings of -$0.16 per share, reflecting a year-over-year decrease of 33.33%.
Earnings History
Price & Consensus
Zacks News for DMAC
Are Medical Stocks Lagging DiaMedica Therapeutics (DMAC) This Year?
DMAC: What are Zacks experts saying now?
Zacks Private Portfolio Services